Vaccines List

Adacel

Adacel is used to help prevent tetanus, diphtheria, and pertussis in people who are at least 10 years old. Most people in this age group require only one Tdap shot for protection against these diseases.Read more...

Afluria

AFLURIA is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B present in the vaccine.Read more...

ASP3772

In Affinivax’s MAPS vaccine against pneumococcus, proprietary pneumococcal protein antigens enable the potential for an additional immune response to protect against disease due to a broader range of ‘non-vaccine’ pneumococcal serotypes, beyond what is covered by today’s vaccines.Read more...

AV7909 - NuThrax - Anthrax

NuThrax™, anthrax vaccine adsorbed with CPG 7909 adjuvant, in the event of a public health emergency involving Bacillus anthracis.Read more...

BEXSERO

BEXSERO is an FDA-approved vaccine to prevent invasive disease caused by Neisseria meningitidis serogroup B.Read more...

Boostrix

BOOSTRIX is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.Read more...

BPZE1 (Whooping Cough)

BPZE1 is a live, attenuated form of the pertussis bacterium. BPZE1 is given as a mist into the nose, rather than a shot in the arm. ILiAD Biotechnologies, LLC (ILiAD) is providing the vaccine.Read more...

Daptacel

DAPTACEL is a vaccine indicated for active immunization against diphtheria, tetanus, and pertussis as a five-dose series in infants and children 6 weeks through 6 years of age (prior to 7th birthday).Read more...

Dengvaxia Dengue

CYD-TDV, sold under the brand name Dengvaxia and made by Sanofi Pasteur, is a live attenuated tetravalent chimeric vaccineRead more...

Egaten

Egaten is currently the only treatment for fascioliasis recommended by the WHO and is on the WHO Model List of Essential Medicines.Read more...

Engerix-B

ENGERIX-B is a vaccine indicated for immunization against infection caused by all known subtypes of hepatitis B virus.Read more...

Flu-v

Flu-v is a synthetic universal flu vaccine candidate offering long-lasting protection across a broad spectrum of influenza which could be given to a much broader population.Read more...

Fluad

FLUAD is a vaccine that helps protect against the flu.Read more...

Fluarix Quadrivalent

FLUARIX QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.Read more...

FLUCELVAX QUADRIVALENT

FLUCELVAX QUADRIVALENT ® (Influenza Vaccine) is the first and only cell culture-based flu vaccine in the United States to help offer protection against 4 flu virus strains for people aged 4 years... Read more...

Flumist Quadrivalent

FluMist Quadrivalent is a vaccine that is sprayed into the nose to help protect against influenza. It can be used in children, adolescents, and adults ages 2 through 49.Read more...

Fluvirin

FLUVIRIN® (Influenza Virus Vaccine) is an inactivated subunit influenza virus vaccine indicated for active immunization of persons aged 4 years and older against influenza disease caused by influenza virus subtypes A and B included in the vaccine.Read more...

Fluzone

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine.Read more...

Fluzone High-Dose

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine.Read more...

Fluzone Intradermal

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine. Fluzone Intradermal Quadrivalent... Read more...

Fluzone Quadrivalent

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine.Read more...

Gardasil

GARDASIL is a vaccine indicated in girls and women 9 through 26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV).Read more...

Gardasil 9

GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) helps protect girls and women ages 9 to 26 against cervical, vaginal, vulvar, and anal cancers and genital warts caused by 9 types of HPV.Read more...

Harvoni

HARVONI is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype (GT) 1, 4, 5 or 6 infection with or without cirrhosis (compensated).Read more...

Havrix

HAVRIX is a vaccine indicated for active immunization against disease caused by hepatitis A virus (HAV).Read more...

Hepagam B

HepaGam B® [Hepatitis B Immune Globulin Intravenous (Human)] is an intravenous immune globulin indicated for the following: Prevention of Hepatitis B recurrence following liver transplant in HBsAg-positive liver transplant patients.Read more...

HEPLISAV-B

HEPLISAV-B is indicated for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.Read more...

HydroVax-001 (West Nile)

HydroVax-001 experimental vaccine was discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University (OHSU) in Portland.Read more...

Imovax

Imovax Rabies is a vaccine indicated for pre-exposure and post-exposure prophylaxis against rabies.Read more...

Infanrix

INFANRIX is a vaccine indicated for active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children 6 weeks to 7 years of age (prior to seventh birthday).Read more...

INO-A002 (Zika)

Inovio's proprietary platform is leading the way forward for activation immunotherapy.Read more...

Ixiaro - Japanese Encephalitis

Ixiaro is indicated for active immunization for the prevention of disease caused by Japanese encephalitis virus (JEV) and is approved for use in individuals 2 months of age and older.Read more...

Kinrix

A single dose of KINRIX is indicated for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis.Read more...

M-001

M-001 is a vaccine candidate designed to provide multi-strain and multi-season protection against current and future, seasonal and pandemic influenza.

BiondVax's proprietary technology utilizes a unique combination of conserved and... Read more...

M2SR

FluGen’s M2SR vaccine utilizes a proprietary M2 deleted, single replication (M2SR) influenza virus.Read more...

mAb114 (Ebola)

mAb114 is a single monoclonal antibody developed by NIAID.Read more...

Menactra

Menactra vaccine is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.Read more...

Menhibrix

MENHIBRIX is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b.Read more...

Menveo

MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.Read more...

MMR II

M-M-R ® II is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months of age or older.

Measles, mumps, and rubella are three common childhood diseases,... Read more...

Modified Vaccinia Ankara (MVA-M1+NP)

Vaccitech’s MVA-M1+NP vaccine candidate aims to prevent a pandemic and seasonal influenza by eliciting broader and more durable immune protection against all “A strains” of the virus, which cannot be achieved by traditional vaccination. Read more...

Mosquirix (RTS,S)

Mosquirix is a vaccine that is given to children aged 6 weeks to 17 months to help protect against malaria caused by the parasite Plasmodium falciparum.Read more...

mRNA-1653

mRNA-1653 is designed to protect against human metapneumovirus (hMPV) and parainfluenza type 3 (PIV3), two viruses that cause respiratory infections. Read more...

NanoFlu - influenza

Novavax's NanoFlu is an influenza vaccine candidate in a phase 2 clinical study.Read more...

NeoVax

NeoVax is a personalized experimental vaccine designed to recognize cancer-specific proteins, called neoantigens, that are present on the individual’s cancer cells but not on normal cells.Read more...

Nexvax2 - Celiac Disease

Nexvax2 is being developed to protect celiac disease (CeD) patients who carry the HLA-DQ2.5 immune recognition genes, from inadvertent gluten exposure.Read more...

NIPRAB

NIPRBA, a pre-clinical vaccine candidate, is a novel recombinant vaccine that shows robust immunization against Nipah virus in animal models.  

Using a modified rabies virus vector, and incorporating a gene from... Read more...

PAMVAC

PAMVAC is a vaccine candidate based on a recombinant fragment of VAR2CSA, the Plasmodium falciparum protein responsible for binding to the placenta via chondroitin sulfate A (CSA).Read more...

Pediarix

PEDIARIX is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis.Read more...

Pedvaxhib

PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age.Read more...

PennVax-GP

PENNVAX®-GP is a developmental vaccine to prevent and treat HIV strains primarily present in Africa, Asia, Europe, and North America.Read more...

Pentacel

Pentacel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis, and invasive disease due to H influenzae type b.Read more...

PF-06482077

PF-06482077 is Pfizer's 20-Valent pneumococcal conjugate vaccine (20vPnC) candidate for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in adults aged 18 years and older.

“While the full extent... Read more...

Pneumovax 23

PNEUMOVAX ® 23 (Pneumococcal Vaccine Polyvalent) is a vaccine indicated for active immunization for the prevention of pneumococcal disease.Read more...

Prevnar 13

Prevnar 13® is a vaccine indicated in children 6 weeks through 17 years (prior to the 18th birthday) for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae.Read more...

PRIORIX (MMR-RIT in Clinical Trial)

PRIORIX is a lyophilized mixed preparation of the attenuated Schwarz measles, RIT 4385 mumps (derived from Jeryl Lynn strain) and Wistar RA 27/3 rubella strains of viruses, separately obtained by propagation either in chick embryo tissue cultures (mumps and measles) or MRC5 human diploid cells (rubella).Read more...

ProQuad

ProQuad is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age.Read more...

PRV-101 (Type 1 Diabetes)

PRV-101 is a polyvalent coxsackievirus B (CVB) vaccine licensed from Vactech, Ltd., which Provention is developing as a potential vaccine for acute coxsackie infection and for the potential prevention of up to 50% of worldwide type 1 diabetes (T1D) cases.Read more...

Quadracel

Quadracel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis. A single dose of Quadracel vaccine is approved for use in children 4 through 6 years of... Read more...

Rabavert

RABAVERT is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups.Read more...

Recombivax HB

RECOMBIVAX HB is indicated for prevention of infection caused by all known subtypes of hepatitis B virus.Read more...

RiVax®

RiVax® is Soligenix’s proprietary vaccine developed to protect against exposure to ricin toxin and is the most advanced vaccine product in the company’s portfolio.Read more...

Rotarix

ROTARIX is a vaccine indicated for the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) when administered as a 2-dose series.Read more...

Rotateq

RotaTeq is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by Types G1, G2, G3, G4, and G9.Read more...

Sabin IPV Polio

Sabin IPV developed by Sinovac Biotech is a liquid trivalent vaccine (0.5 mL/dose) for intramuscular injection. It was generated from Sabin poliovirus type 1, 2, and 3 strains grown on... Read more...

scMAYV-E (Mayaro Virus)

The scMAYV-E DNA vaccine was administered to mice by intramuscular injection followed by pulses of electricity designed to make cells more permeable to foreign DNA and enhance vaccine uptake, which allows for dose-sparing.Read more...

Shingrix

SHINGRIX is an FDA-approved vaccine for the prevention of shingles (herpes zoster) in adults 50 years and older.Read more...

Stamaril Yellow Fever

Sanofi Pasteur confirms that YF-VAX® (Yellow Fever Vaccine) is unavailable to order in the U.S. until mid-2019 as the company transitions production to a new state-of-the-art facility.Read more...

TAK-003 Dengue

TAK-003 is an investigational live-attenuated tetravalent dengue vaccine, preventing dengue fever caused by any of the four serotypes of the dengue virus.

On January 29, 2019, Takeda announced TAK-003 which is in... Read more...

TAK-426 Zika

 TAK-426  (PIZV) is Takeda’s purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate.

Takeda’s Zika vaccine candidate is currently being studied in a Phase 1 trial (ZIK-101) which was last updated on March... Read more...

Trumenba

Trumenba is a vaccine indicated for individuals 10 through 25 years of age for active immunization to prevent invasive disease caused by Neisseria meningitidis group B.Read more...

Truvada

TRUVADA for PrEP (pre-exposure prophylaxis) is a prescription medicine that is used together with safer sex practices to help reduce the risk of getting HIV-1 through sex.Read more...

Twinrix

TWINRIX is a vaccine indicated for active immunization against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus.Read more...

TY014 Yellow Fever

TY014 will be the first therapeutic in the world, specifically targeting Yellow Fever Virus (YFV), to enter clinical trials. It is anticipated that a monoclonal antibody therapeutic could be administered... Read more...

Typhim VI

TYPHIM Vi is manufactured by Sanofi Pasteur for intramuscular use for protection against Typhoid Fever.Read more...

UB-311

UB-311, a novel synthetic peptide vaccine targeting beta amyloid (Aβ) in the treatment of Alzheimer's disease.Read more...

V920 Ebola

Merck's V920  (rVSVΔG-ZEBOV-GP)  investigational vaccine candidate to prevent the onset of Ebola Zaire, is a prime/boost candidate vaccine based on Ad26- and MVA-vectored components (Ad26.ZEBOV/MVA-BN-Filo) and the Ad5-EBOV candidate vaccine.... Read more...

Vaqta

VAQTA is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older.Read more...

Varivax

VARIVAX is a vaccine indicated for active immunization for the prevention of varicella (ChickenPox) in individuals 12 months of age or older.Read more...

Varizig

VARIZIG [Varicella Zoster Immune Globulin (Human)] is indicated in the United States for post-exposure prophylaxis of varicella (chickenpox) in high risk patient groups including immunocompromised children, newborns, and pregnant women.Read more...

Vaxchora

Vaxchora is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1 in adults 18 through 64 years of age traveling to cholera-affected areas.Read more...

VGX-3100 HPV

VGX-3100 is an investigational immunotherapy designed to treat pre-cancers and cancers caused by human papillomavirus (HPV).

VGX-3100 includes DNA plasmids targeting the E6 and E7 proteins of HPV types 16... Read more...

Vivotif

Vivotif is an oral vaccine for typhoid fever, a potentially severe and life-threatening infection caused by the bacterium Salmonella enterica serotype Typhi (S Typhi).Read more...

VLA15 Lyme Disease

VLA15 is a multivalent vaccine that targets the outer surface protein A (OspA) of Borrelia and is under Fast Track Designation by the Food and Drug Administration (FDA). Read more...

VLA1553 Chikungunya Vaccine Candidate

Valneva initiated a Phase 1 clinical trial in the US to evaluate the safety and immunogenicity of VLA1553, its live-attenuated vaccine candidate against chikungunya.Read more...

VXA‑G1.1-NN (Norovirus)

VXA-G1.1-NN is an Oral Vaccine Tablet addressing Norovirus.Read more...

YF-VAX Yellow Fever

YF-VAX is indicated for active immunization for the prevention of yellow fever in persons 9 months of age and older.Read more...

Zostavax

ZOSTAVAX is a single shot vaccine for adults 50 years of age or older that helps to boost the immune system against Shingles.Read more...